Financhill
Buy
86

HALO Quote, Financials, Valuation and Earnings

Last price:
$62.24
Seasonality move :
4.16%
Day range:
$61.11 - $62.72
52-week range:
$37.73 - $65.53
Dividend yield:
0%
P/E ratio:
18.15x
P/S ratio:
7.93x
P/B ratio:
21.07x
Volume:
1M
Avg. volume:
1.3M
1-year change:
52.61%
Market cap:
$7.7B
Revenue:
$1B
EPS (TTM):
$3.43

Halozyme Therapeutics SEC Filings

Company Filed Form Type Description
HALO
Halozyme Therapeutics
05/07/2024 10-Q 10-Q filing on 05/07/2024 View Form
HALO
Halozyme Therapeutics
11/06/2023 10-Q 10-Q filing on 11/06/2023 View Form
HALO
Halozyme Therapeutics
08/08/2023 10-Q 10-Q filing on 08/08/2023 View Form
HALO
Halozyme Therapeutics
05/09/2023 10-Q 10-Q filing on 05/09/2023 View Form
HALO
Halozyme Therapeutics
11/08/2022 10-Q 10-Q filing on 11/08/2022 View Form
HALO
Halozyme Therapeutics
08/09/2022 10-Q 10-Q filing on 08/09/2022 View Form
HALO
Halozyme Therapeutics
05/10/2022 10-Q 10-Q filing on 05/10/2022 View Form
HALO
Halozyme Therapeutics
11/02/2021 10-Q 10-Q filing on 11/02/2021 View Form
HALO
Halozyme Therapeutics
08/09/2021 10-Q 10-Q filing on 08/09/2021 View Form
HALO
Halozyme Therapeutics
05/10/2021 10-Q 10-Q filing on 05/10/2021 View Form
HALO
Halozyme Therapeutics
11/02/2020 10-Q 10-Q filing on 11/02/2020 View Form
HALO
Halozyme Therapeutics
08/10/2020 10-Q 10-Q filing on 08/10/2020 View Form
HALO
Halozyme Therapeutics
05/11/2020 10-Q 10-Q filing on 05/11/2020 View Form
HALO
Halozyme Therapeutics
02/24/2020 10-K 10-K filing on 02/24/2020 View Form
HALO
Halozyme Therapeutics
11/12/2019 10-Q 10-Q filing on 11/12/2019 View Form
HALO
Halozyme Therapeutics
08/06/2019 10-Q 10-Q filing on 08/06/2019 View Form
HALO
Halozyme Therapeutics
05/07/2019 10-Q 10-Q filing on 05/07/2019 View Form
HALO
Halozyme Therapeutics
02/21/2019 10-K 10-K filing on 02/21/2019 View Form
HALO
Halozyme Therapeutics
11/06/2018 10-Q 10-Q filing on 11/06/2018 View Form
HALO
Halozyme Therapeutics
08/07/2018 10-Q 10-Q filing on 08/07/2018 View Form
HALO
Halozyme Therapeutics
05/10/2018 10-Q 10-Q filing on 05/10/2018 View Form
HALO
Halozyme Therapeutics
02/20/2018 10-K 10-K filing on 02/20/2018 View Form
HALO
Halozyme Therapeutics
11/07/2017 10-Q 10-Q filing on 11/07/2017 View Form
HALO
Halozyme Therapeutics
08/08/2017 10-Q 10-Q filing on 08/08/2017 View Form
HALO
Halozyme Therapeutics
05/09/2017 10-Q 10-Q filing on 05/09/2017 View Form
HALO
Halozyme Therapeutics
02/28/2017 10-K 10-K filing on 02/28/2017 View Form
HALO
Halozyme Therapeutics
11/07/2016 10-Q 10-Q filing on 11/07/2016 View Form
HALO
Halozyme Therapeutics
08/09/2016 10-Q 10-Q filing on 08/09/2016 View Form
HALO
Halozyme Therapeutics
05/09/2016 10-Q 10-Q filing on 05/09/2016 View Form
HALO
Halozyme Therapeutics
02/29/2016 10-K 10-K filing on 02/29/2016 View Form
HALO
Halozyme Therapeutics
11/09/2015 10-Q 10-Q filing on 11/09/2015 View Form
HALO
Halozyme Therapeutics
08/11/2015 10-Q 10-Q filing on 08/11/2015 View Form
HALO
Halozyme Therapeutics
08/10/2015 10-Q 10-Q filing on 08/10/2015 View Form
HALO
Halozyme Therapeutics
05/11/2015 10-Q 10-Q filing on 05/11/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Reddit a Buy on the Dip?
Is Reddit a Buy on the Dip?

Reddit (NYSE:RDDT) share price has been on the proverbial ropes…

Qualcomm Stock: 5G Leader at a Bargain Price?
Qualcomm Stock: 5G Leader at a Bargain Price?

Chip giant QUALCOMM Incorporated (NASDAQ:QCOM) was the ultimate chip company…

What Is Buffett Buying and Selling Now?
What Is Buffett Buying and Selling Now?

In Q4 of last year, Warren Buffett made a few…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
59
GRRR alert for Mar 15

Gorilla Technology Group [GRRR] is up 29.72% over the past day.

Sell
49
SMTC alert for Mar 15

Semtech [SMTC] is up 21.28% over the past day.

Buy
62
PLPC alert for Mar 15

Preformed Line Products [PLPC] is up 17.38% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock